MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Oxybuprocaine.
Acepromazine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Aceprometazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Oxybuprocaine.
Alphaprodine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Oxybuprocaine.
Amisulpride
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxybuprocaine.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Oxybuprocaine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Oxybuprocaine.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Oxybuprocaine.
Articaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Oxybuprocaine.
Azelastine
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Oxybuprocaine.
Barbital
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Barbital.
Benperidol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Oxybuprocaine.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Oxybuprocaine.
Bromperidol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Oxybuprocaine.
Brotizolam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Oxybuprocaine.
Buprenorphine
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Oxybuprocaine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxybuprocaine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Oxybuprocaine.
Butamben
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxybuprocaine.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxybuprocaine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Oxybuprocaine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxybuprocaine.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Oxybuprocaine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Oxybuprocaine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Oxybuprocaine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Oxybuprocaine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Oxybuprocaine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Oxybuprocaine.
Citalopram
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Oxybuprocaine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Oxybuprocaine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Oxybuprocaine.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Oxybuprocaine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Oxybuprocaine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Oxybuprocaine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Oxybuprocaine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Oxybuprocaine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Oxybuprocaine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Oxybuprocaine.
Cocaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Oxybuprocaine.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Oxybuprocaine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Oxybuprocaine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Oxybuprocaine.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Oxybuprocaine.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Oxybuprocaine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Oxybuprocaine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Oxybuprocaine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxybuprocaine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Oxybuprocaine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Oxybuprocaine.
Dextromoramide
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Oxybuprocaine.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Oxybuprocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Oxybuprocaine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Oxybuprocaine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Oxybuprocaine.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Oxybuprocaine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Oxybuprocaine.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Oxybuprocaine.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Duloxetine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Oxybuprocaine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Oxybuprocaine.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Oxybuprocaine.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Oxybuprocaine.
Escitalopram
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Oxybuprocaine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxybuprocaine.
Ethanol
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Oxybuprocaine.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Oxybuprocaine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Oxybuprocaine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Oxybuprocaine.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Oxybuprocaine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Oxybuprocaine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Oxybuprocaine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Oxybuprocaine.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Oxybuprocaine.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Oxybuprocaine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Oxybuprocaine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxybuprocaine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Oxybuprocaine.
Fluspirilene
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Oxybuprocaine.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxybuprocaine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Oxybuprocaine.
Fospropofol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Oxybuprocaine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Oxybuprocaine.
Glutethimide
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Oxybuprocaine.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Oxybuprocaine.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Oxybuprocaine.
Halothane
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Hexobarbital.
Hyaluronidase
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Oxybuprocaine.
Hyaluronidase, Ovine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Oxybuprocaine.
Hydrocodone
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxybuprocaine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Oxybuprocaine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Oxybuprocaine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Oxybuprocaine.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Oxybuprocaine.
Ketazolam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Oxybuprocaine.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Oxybuprocaine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Oxybuprocaine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Oxybuprocaine.
Levomethadyl
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Oxybuprocaine.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Oxybuprocaine.
Lithium
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Lithium.
Lofexidine
The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Oxybuprocaine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Oxybuprocaine.
Lormetazepam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxybuprocaine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Oxybuprocaine.
Magnesium Sulfate
The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxybuprocaine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Oxybuprocaine.
Melatonin
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxybuprocaine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Oxybuprocaine.
Mepivacaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Oxybuprocaine.
Mesoridazine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Oxybuprocaine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Oxybuprocaine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Oxybuprocaine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Oxybuprocaine.
Methotrimeprazine
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Oxybuprocaine.
Metylperon
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Melperone.
Metyrosine
Oxybuprocaine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Oxybuprocaine.
Milnacipran
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Mirtazapine
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Oxybuprocaine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxybuprocaine.
Nefazodone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Oxybuprocaine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Oxybuprocaine.
Nordazepam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Oxybuprocaine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Oxybuprocaine.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Oxybuprocaine.
Ondansetron
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Opium.
Orphenadrine
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Oxybuprocaine.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Oxybuprocaine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Oxybuprocaine.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Oxybuprocaine.
Paraldehyde
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Oxybuprocaine.
Paroxetine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Oxybuprocaine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Oxybuprocaine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Perazine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Oxybuprocaine.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Oxybuprocaine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Phenoxyethanol.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Oxybuprocaine.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Oxybuprocaine.
Pipamperone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Oxybuprocaine.
Pirinitramide
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxybuprocaine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxybuprocaine.
Pramipexole
Oxybuprocaine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Oxybuprocaine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Oxybuprocaine.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Oxybuprocaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Oxybuprocaine.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Oxybuprocaine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Oxybuprocaine.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Oxybuprocaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Oxybuprocaine.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Oxybuprocaine.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Oxybuprocaine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Oxybuprocaine.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxybuprocaine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxybuprocaine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Oxybuprocaine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Oxybuprocaine.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Oxybuprocaine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Oxybuprocaine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Oxybuprocaine.
Ropinirole
Oxybuprocaine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Oxybuprocaine.
Rotigotine
Oxybuprocaine may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxybuprocaine.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybuprocaine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybuprocaine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Oxybuprocaine.
Sertindole
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Oxybuprocaine.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Oxybuprocaine.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Oxybuprocaine.
Suvorexant
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Oxybuprocaine.
technetium Tc 99m tilmanocept
Oxybuprocaine may decrease effectiveness of Technetium Tc-99m tilmanocept as a diagnostic agent.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Oxybuprocaine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Oxybuprocaine.
Tetracaine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Thalidomide
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Oxybuprocaine.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Oxybuprocaine.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Oxybuprocaine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Oxybuprocaine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Oxybuprocaine.
Tiapride
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Oxybuprocaine.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Oxybuprocaine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Oxybuprocaine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Oxybuprocaine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Oxybuprocaine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Oxybuprocaine.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Oxybuprocaine.
Triazulenone
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxybuprocaine.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Oxybuprocaine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Oxybuprocaine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Oxybuprocaine.
Urethane
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Oxybuprocaine.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Oxybuprocaine.
Venlafaxine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Oxybuprocaine.
Vortioxetine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Oxybuprocaine.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Oxybuprocaine.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Oxybuprocaine.
Zolpidem
Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Oxybuprocaine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Oxybuprocaine.
Zotepine
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Oxybuprocaine.
